Neuro examination,Alzheimer's, Multiple Sclerosis and Diabetic Neuropathy
As a fellowship-trained neurologist subspecializing in movement disorders, Dr. Zhang’s primary clinical and research interests are in Parkinson's disease (PD), tremor, ataxia, and other movement disorders. His particular expertise has led him to focus on the epidemiology of PD, exploring whether nutritional deficiencies in certain populations have an impact on PD. He currently serves as Chair of the Working Group on Genetic & Environmental Risk Factors for PD as part of the largest clinical research consortium in the country, the Parkinson Study Group (PSG). As a member site for PSG, the clinical trial program he leads at UC Davis has participated in many multicenter trials testing new medications for PD, several of which are now used in clinical practice. Dr. Zhang’s other clinical and research interests focus on dystonia and related movement disorders such as facial spasm, limb spasticity, and dystonic tremor, all of which can be treated with neurotoxin injections, most commonly botox. He has participated in registry studies and double-blinded clinical trials for neurotoxin therapeutics, and his services presently offer four different types of neurotoxins to accommodate the patient's needs, symptoms, previous exposure to other toxins, and a variety of other indications. Dr. Zhang also serves as the medical director of the Deep Brain Stimulation (DBS) program at UC Davis and he is very interested in the clinical applications of DBS. Under his direction the DBS program of UCDavis has become a referral center that offers implantation surgery weekly and clinical programming visits daily, serving the greater Sacramento area and northern California.
Deep Brain Stimulation
Professor of Pathophysiology Marina Zueva graduated from the Lomonosov Moscow State University (Physiology of Higher Nervous Activity). She received her Ph.D. degree in 1980 and then the degree of Doctor of Biol Sci in 1997 from Moscow Helmholtz Research Institute of Eye Diseases. From 1973 to present time she works in the Department of Clinical Physiology of Vision at Moscow Helmholtz Research Institute of Eye Diseases. Current position - the Head of the Department. In 2017, she founded and became a General Director of the LTD “Center of Neurocognitive Technologies “Cognito”.” Marina Zueva is a member of International Society of Clinical Electrophysiology of Vision (ISCEV), European Association for Vision and Eye Research (EVER), European Society of Retina Specialists (EURETINA) and some other scientific Societies. She has published over 15 peer-reviewed papers in English and over 100 in Russian, 13 Chapters in the books (one – in English) and presented over 70 topics at international conferences. Research Topics: Basic and clinical physiology and electrophysiology of vision, neurophysiology; Age-related, developmental and neurodegenerative disorders of the visual system and brain, neurocognitive technologies in the diagnosis and treatment of diseases of the retina and brain.
Alzheimer's Disease and Dementia
Alzheimer's Disease and Dementia
Hannes Richter is Head of the Department of “Nanoporous Membranes”. For his thesis on ceramic nanofiltration membranes (1998), he received the Bernhard-von-Cotta Award of the Freiberg University. He is experienced in amorphous membranes for 20 years and in zeolite and carbon membranes for more than 10 years. For the development of NaA-membranes and its scaling-up in to an industrial level, he received the Exceptional price of “Junior Scientist Award” competition at Materialsweek 2004, the “Innovation Award Middle Germany 2008 - Cluster Energy and Environment” and “Innovation Award Energy 2009” of the Society for the Promotion of Renewable Energy. For the development of ceramic nanofiltration membranes with a cut-off of 200 Da, he won the “Fraunhofer Award 2017”. He is the author of about 38 papers, gave more than 70 lectures in national and international congresses, thereof 26 invited presentations and is inventor of 8 patents.
Alzheimer's Disease and Dementia
Stephen D. Skaper received a PhD in biochemistry from the University of South Dakota and Laurea in chemistry from the University of Padua, Italy. He is currently Adjunct Professor in the Department of Pharmaceutical and Pharmacological Sciences (section on Pharmacology and Anesthesiology) at the University of Padua. From 1998-2008 he was a Senior Group Leader for Neurodegeneration Research, Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline Research and Development Limited, United Kingdom. Prior to that he held academic research positions in the Departments of Medicine and Biology at the University of California, San Diego. Dr. Skaper has authored/co-authored over 300 research papers, book chapters and monographs, as well as having guest-edited six journal thematic issues and two volumes of Methods in Molecular Biology on neurotrophic factors. He is Editor-in-Chief of CNS & Neurological Disorders Drug Targets, Associate Editor of the American Journal of Neuroprotection and Neuroregeneration, handling editor for Scientific Reports, and a Councilor of the International Association of Neurorestoratology. His research interests focus on the role of immune cells and their interactions in neuroinflammation, in particular with regards to neuropathic pain and multiple sclerosis, and the development of therapeutic strategies based on natural molecules. He is a member of Sigma ?I, Phi Lambda Upsilon, Alpha Chi Sigma, the Society for Neuroscience and the International Society of Cerebral Blood Flow and Metabolism.
Dr. Alain L Fymat is a medical-physical scientist and an educator. He was educated at the University of Paris-Sorbonne and the University of California at Los Angeles. He is the current President/CEO and Professor at the International Institute of Medicine and Science with a previous appointment as Executive Vice President, Chief Operating Officer and Professor at the Weil Institute of Critical Care Medicine. He was formerly Professor of Radiology, Radiological Sciences, Radiation Medicine (Oncology), Critical Care Medicine, and Physics at several U.S. and European Universities. Previously, he was Deputy Director (Western Region) of the U.S. Department of Veterans Affairs, Veterans Health Administration (Office of Research Oversight), and Director of the Magnetic Resonance Imaging Center and for a time Acting Chair of Radiology at its Loma Linda, California Medical Center. He has extensively published (~ 400 publications including patents, books & monographs, book chapters, refereed articles) and has lectured extensively in the USA, Europe, Africa and Asia. He has been the recipient of numerous research grants from government, academia and private industry, and has consulted extensively with these entities. He is a Board member of several institutions and Health Advisor of the American Heart & Stroke Association (Coachella Valley Division, California). He is Editor-in-Chief, Honorable Editor or Editor of 25 scientific Journals
Hans von Holst received his Medical Doctor´s degree in 1976 and specialist in Neurosurgery 1982 at Karolinska University Hospital. In 1985 he earned his PhD and Associate Professorship in Neurosurgery, Clinical Neuroscience at Karolinska Institutet. During 1991-1996 he was appointed as Chairman of the Dept of Neurosurgery and Division Manager of the Neuroclinics at Karolinska University Hospital, respectively. In 1995 he became Professor in Neuroengineering at the Royal Institute of Technology. He has published around 140 original papers in reputed journals, reviews and books and has been serving as an editorial board member in several journals.
Neurosurgery and Neuroengineering